| Tag | Content |
|---|
EnhancerAtlas ID | HS139-43890 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr5:79420950-79422620 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESRRB | MA0141.3 | chr5:79421441-79421452 | AATGACCTTGA | - | 6.32 | | Esrra | MA0592.2 | chr5:79421442-79421453 | ATGACCTTGAA | - | 6.62 | | Esrrg | MA0643.1 | chr5:79421442-79421452 | ATGACCTTGA | - | 6.02 | | FOSL2 | MA0478.1 | chr5:79421836-79421847 | ATGAGTCATCC | - | 6.62 | | JUNB | MA0490.1 | chr5:79421836-79421847 | ATGAGTCATCC | - | 6.62 | | RARA(var.2) | MA0730.1 | chr5:79421626-79421643 | GGGTCAAGAAAAGGACA | + | 6.17 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09667 | chr5:79416931-79425150 | CD14 | | SE_18330 | chr5:79419789-79423397 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I080124 | chr5 | 79420286 | 79423422 |
|
Enhancer Sequence | TCCATTCATT CATTCATATA GCAAACAATT GTACATCACA ACCTTATGCT AGGTGCTAGG 60
TATACAATGA TAAAACAAAC ACAAAAACCA AAACCACAAT CTCTACCCTC AATGTGAGGA 120
GATACCACCA CATAAACGAA CAATTACAAT ACTGTGAAAC ATGTTATGCT CAATCTATGG 180
CCTAAATCAG ATGAGAGGCT GGGCAGAGGA TCAGGCTGCC AAGAAATGCT TCCTAGAGGG 240
CATGCTGCCC GAAATGAACC TTGAAAATCA GGGAGCTTGA TAGAAATAGG GAAAGAGAGA 300
GTGTTTCAGG CAGAAGCAAG GTTCACTGTC AAGGAAAGGC ATTTCAGGAA ACCAAAAGTA 360
GTATCTGTTT GACATGAGCT ATATTGGAGT GAGAGTACTG GGAGGTAGGC TAGAAAGGGG 420
AACAGAGACT AGATATGAAG GAACTTGAAA GCCGTAAGTA TATGAAGAAG GCAATGGGCT 480
TTCTACACAG GAATGACCTT GAAGACTTGA TTTGCATTAT TGAAAGCTCA CCATGGCTGG 540
AATGGATTGG GGACGTCCGA TGATGGGAAG ACTCAGCTGG GCAGTTGCTG CATTAACTGT 600
GGAGTTATAA TGGTGACCTA CGAGAGCAGC TTTGGATACG GAGAAGAGCA AACTGGTTTA 660
AGAAACGTCA TCACCTGGGT CAAGAAAAGG ACATGCAGTG GGTTGGGTAG GGAGGAAAAT 720
AGATGTAAAT AAAGTTATTA GTTGAAAAAG AAAAGCAAGA TCGAGAGAGA AATTAATTCT 780
ATTGCCATCT ATTCATGAGA ATCACAAGGC TGAATCAAAA GCCTTCCTGC AAACCTAGAC 840
TCACGCTGGT TCAGTTCAGA GACTCTATCA GAAAGATGAG GAGCTCATGA GTCATCCATC 900
AATGTGATCT TGTGATTTTT CTTGTGACCA CAAGACAAAG GAAGAGAAGA GTACTTTGGA 960
GTCATTATGA TGAAAATTCA GTTGAATACA CTGGAAAGTC AAAACGAGAG GAGAAGGAGG 1020
AACCGAAAAT CTGATTCAGT CTTGACCACC AAGTAGAATT GGGACAGAAA CAATTAAGTA 1080
GGCACAGATC CAATTTGGAT TATAAAAAGC TGGTTCATCA GGAAGGCCAC TATAAAACCA 1140
GAAGCAAACG AAGAGTCAAT TAAGTACAAA AGTTTTTACT ATGACTATGC AGTGAGGTCC 1200
AAACTGTACT AAATTTGAAG TTCCCTGCCA AAGAGAAATG TAAGCTTCCC TGGTGGTATA 1260
AGTCAGAATT TCATGACATC AGCCAGATAA CCACAAAAGA ATATATCTTT TAGTGCTAGA 1320
TGCTTCTAAG CCTTTCTCCA CCCAACTAAC CAACATTCAC TTACTGATTT ACTTATTTCT 1380
TTAACAAACA CACTCCATTT CATAGCCACA TTCTTTCAAA GCTGACAGGT TGAGATATAT 1440
CTAAAACACA AAATCTCCAA CATACATTTT CTTCTTCAAT GTTGTGAGAT GTATTTTTCT 1500
AAAACACTGT TCTGCACATA CTACCATTCC AATATTAAAA ACAAGTTAGT TATCCACTGC 1560
CTTTTTTGTA CAAATGAAAT TCATAAATTT TAATTTGGTT ACAAAAAAAT TTTTCATCAA 1620
AATTTTTGCT TATTTGTTTA TATAAAAATG GAGACAGGGT CTCACTATGT 1670
|
